|
Cash Flow for
IDEXX Laboratories Inc.
(IDXX)
|
|
|
|
|
|
|
| Cash Flow |
in Thousands of Dollars |
|
|
| Net Income |
178,287 |
161,754 |
141,320 |
122,235 |
116,169 |
| Depreciation |
52,408 |
48,202 |
45,956 |
49,773 |
47,984 |
| Amortization |
- |
- |
- |
- |
- |
| Amortization of Intagibles |
- |
- |
- |
- |
- |
| Deferred Income Taxes |
(1,970) |
5,996 |
(908) |
3,270 |
5,634 |
| Operating Gains/Losses |
(3,274) |
615 |
1,599 |
474 |
2,314 |
| Extraordinary Gains/Losses |
- |
- |
- |
- |
- |
| Decrease in Receivables |
3,487 |
(24,809) |
(6,914) |
(1,155) |
(10,266) |
| Decrease in Inventories |
(13,752) |
(6,310) |
(19,469) |
6,223 |
(18,468) |
| Decrease in Prepaid Expenses |
- |
- |
- |
- |
- |
| Decrease in Other Current Assets |
- |
- |
- |
- |
- |
| Increase in Payables |
(1,304) |
13,884 |
3,482 |
(9,156) |
(4,327) |
| Increase in Other Current Liabilities |
3,011 |
17,564 |
30,604 |
705 |
4,257 |
| Decrease in Other Working Capital |
10,821 |
6,002 |
(10,838) |
(6,917) |
(4,707) |
| Other Non-Cash Items |
2,568 |
(2,198) |
(5,999) |
9,500 |
4,718 |
| Net Cash from Continuing Operations |
230,282 |
220,700 |
178,833 |
174,952 |
143,308 |
| Net Cash from Discontinued Operations |
- |
- |
- |
- |
- |
| Cash from Operating Activities |
230,282 |
220,700 |
178,833 |
174,952 |
143,308 |
|
|
| Sale of Property, Plant, Equipment |
45 |
225 |
112 |
2,079 |
- |
| Sale of Long Term Investments |
- |
- |
- |
- |
- |
| Sale of Short Term Investments |
- |
- |
- |
- |
- |
| Purchase of Property, Plant, Equipment |
(66,392) |
(53,464) |
(39,302) |
(51,163) |
(98,620) |
| Acquisitions |
342 |
(43,757) |
- |
(4,537) |
7,025 |
| Purchase of Long Term Investments |
- |
- |
- |
- |
- |
| Purchase of Short Term Investments |
- |
- |
- |
- |
- |
| Other Investment Changes, Net |
(900) |
- |
(4,000) |
- |
- |
| Cash from Investing Activities |
(66,005) |
(96,996) |
(43,190) |
(53,621) |
(91,595) |
| Cash from Discontinued Investing Activities |
- |
- |
- |
- |
- |
|
| Issuance of Debt |
- |
- |
- |
- |
79,550 |
| Issuance of Capital Stock |
24,166 |
28,801 |
28,865 |
16,366 |
16,360 |
| Repayment of Debt |
(917) |
(863) |
(813) |
(926) |
(595) |
| Repurchase of Capital Stock |
(132,268) |
(255,505) |
(143,090) |
(83,099) |
(132,342) |
| Payment of Cash Dividends |
- |
- |
- |
- |
- |
| Other Financing Charges, Net |
(16,324) |
129,910 |
28,269 |
(27,636) |
6,237 |
| Cash from Financing Activities |
(125,343) |
(97,657) |
(86,769) |
(95,295) |
(30,790) |
| Cash from Discontinued Financing Activities |
- |
- |
- |
- |
- |
|
|
| Effect of Exchange Rate Changes |
1,157 |
933 |
1,313 |
1,824 |
(2,415) |
| Net Change in Cash |
40,091 |
26,980 |
50,187 |
27,860 |
18,508 |
|
| Cash at Beginning of Year |
183,895 |
156,915 |
106,728 |
78,868 |
60,360 |
| Cash at End of Period |
223,986 |
183,895 |
156,915 |
106,728 |
78,868 |
| Foreign Sales |
444,613 |
432,850 |
- |
- |
- |
| Domestic Sales |
848,725 |
785,839 |
- |
- |
- |
|
|
|
